FMP
Silo Pharma, Inc.
SILO
PNK
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
1.98 USD
0.016 (0.81%)
About
ceo
Mr. Eric Weisblum
sector
Healthcare
industry
Biotechnology
website
https://silopharma.com
exchange
PNK
Description
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
CIK
0001514183
ISIN
US82711P2011
CUSIP
82711P102
Address
560 Sylvan Avenue
Phone
718 400 9031
Country
US
Employee
3
IPO Date
Jan 8, 2021
Summary
CIK
0001514183
Exchange
PNK
Industry
Biotechnology
Sector
Healthcare
CUSIP
82711P102
ISIN
US82711P2011
Country
US
Price
1.98
Beta
1.35
Volume Avg.
134.52k
Market Cap
5.62M
Shares
-
52-Week
1.216-3.05
DCF
0.63
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.67
P/B
-
Website
https://silopharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SILO News
It looks like there's no news available.
